HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy and safety of intracameral triamcinolone acetonide to control postoperative inflammation after phacotrabeculectomy.

AbstractPURPOSE:
To evaluate the efficacy and safety of intracameral triamcinolone acetonide in phacotrabeculectomy.
SETTING:
Beijing Shijitan Hospital, Capital University of Medical Sciences, Beijing, China.
DESIGN:
Prospective randomized controlled trial.
METHODS:
Patients having combined trabeculectomy and cataract surgery were enrolled from March 2010 through January 2012. The patients were randomly divided into 4 groups. At the conclusion of the surgery, Group A received intracameral triamcinolone acetonide 0.5 mg, Group B received triamcinolone acetonide 1.0 mg, Group C received triamcinolone acetonide 2.0 mg. Group D was the control group and did not receive triamcinolone acetonide. All patients had a conventional 2-side trabeculectomy and phacoemulsification with foldable posterior chamber intraocular lens implantation. Visual acuity and clinical indexes of anterior segment inflammation were assessed 1, 7, 14, and 28 days postoperatively.
RESULTS:
One hundred twenty-six eyes of 126 patients with a mean age of 64.09 years ± 8.22 (SD) were enrolled. The eyes treated with triamcinolone acetonide had better visual acuity and less anterior chamber inflammation than the control eyes. Intracameral triamcinolone acetonide was highly effective in controlling postoperative inflammation in phacotrabeculectomy, and triamcinolone acetonide 1.0 mg provided the best postoperative result.
CONCLUSION:
Intracameral injection of triamcinolone acetonide in phacotrabeculectomy resulted in a significant reduction in aqueous inflammation and improvement in visual acuity.
AuthorsBingsong Wang, Ning Dong, Bing Xu, Jing Liu, Lin Xiao
JournalJournal of cataract and refractive surgery (J Cataract Refract Surg) Vol. 39 Issue 11 Pg. 1691-7 (Nov 2013) ISSN: 1873-4502 [Electronic] United States
PMID24160382 (Publication Type: Journal Article, Randomized Controlled Trial)
CopyrightCopyright © 2013. Published by Elsevier Inc.
Chemical References
  • Glucocorticoids
  • Triamcinolone Acetonide
Topics
  • Aged
  • Aged, 80 and over
  • Anterior Chamber (drug effects)
  • Female
  • Glucocorticoids (adverse effects, therapeutic use)
  • Humans
  • Injections, Intraocular
  • Intraocular Pressure (physiology)
  • Lens Implantation, Intraocular
  • Male
  • Middle Aged
  • Phacoemulsification
  • Postoperative Complications
  • Prospective Studies
  • Pseudophakia (physiopathology)
  • Refraction, Ocular (physiology)
  • Tonometry, Ocular
  • Trabeculectomy
  • Treatment Outcome
  • Triamcinolone Acetonide (adverse effects, therapeutic use)
  • Uveitis, Anterior (etiology, prevention & control)
  • Visual Acuity (physiology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: